发明名称 |
A NOVEL COMPOUND FOR THE TREATMENT OF HEPATITIS C |
摘要 |
The present invention provides (R)-5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamoyl)phenyl)-6-(sec-butyl)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide (formula I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. |
申请公布号 |
EP3080106(A1) |
申请公布日期 |
2016.10.19 |
申请号 |
EP20140824625 |
申请日期 |
2014.12.08 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
YEUNG, KAP-SUN;GRANT-YOUNG, KATHARINE, A. |
分类号 |
C07D413/12;A61K31/4245;A61P31/12 |
主分类号 |
C07D413/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|